Chemours Company Faces Securities Fraud Lawsuit Over Opteon Demand Claims
2 days ago
A class action lawsuit alleges Chemours made misleading statements regarding Opteon product demand and 2026 fiscal guidance. Investors purchasing shares between February and August 2026 are encouraged to contact SBS Law regarding potential lead plaintiff appointments.
Show all 139 updates